Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

Nobendu Mukerjee*, Swastika Maitra, Subhradeep Roy, Shaswata Modak, Mohammad Mehedi Hasan, Biswajit Chakraborty, Arabinda Ghosh, Asmita Ghosh, Mohammad Amjad Kamal, Abhijit Dey, Ghulam Md Ashraf, Sumira Malik, Md Habibur Rahman, Badrah S. Alghamdi, Adel Mohammad Abuzenadah, Athanasios Alexiou*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)

Abstract

Glioblastoma (GB) are aggressive tumors that obstruct normal brain function. While the skull cannot expand in response to cancer growth, the growing pressure in the brain is generally the first sign. It can produce more frequent headaches, unexplained nausea or vomiting, blurred peripheral vision, double vision, a loss of feeling or movement in an arm or leg, and difficulty speaking and concentrating; all depend on the tumor’s location. GB can also cause vascular thrombi, damaging endothelial cells and leading to red blood cell leakage. Latest studies have revealed the role of single nucleotide polymorphisms (SNPs) in developing and spreading cancers such as GB and breast cancer. Many discovered SNPs are associated with GB, particularly in great abundance in the promoter region, creating polygenetic vulnerability to glioma. This study aims to compile a list of some of the most frequent and significant SNPs implicated with GB formation and proliferation.

Original languageEnglish
Pages (from-to)61-68
Number of pages8
JournalMetabolic Brain Disease
Volume38
Issue number1
DOIs
Publication statusPublished - Jan 2023
Externally publishedYes

Keywords

  • Epidermal growth factors receptor
  • Glioblastoma
  • Single nucleotide polymorphisms
  • Tumors

Fingerprint

Dive into the research topics of 'Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme'. Together they form a unique fingerprint.

Cite this